HR 6412119th CongressIn Committee
Independence Investment Fund Act
Standard Summary
Balanced plain-English summary
The Independence Investment Fund Act would create a Treasury-administered fund to make equity investments in U.S.-headquartered companies developing critical and emerging technologies, with biotechnology as a priority, to strengthen national and economic security and counter adversarial foreign investment. It establishes advisory and supervisory boards, a competitively selected managing entity, reporting requirements, personnel authorities, exemptions from certain laws, and authorizes appropriations.
Key Points
- 1Creates an Independence Investment Fund within the Treasury to invest in critical and emerging technology companies.
- 2Prioritizes biotechnology and seeks average equity investments between $1 million and $10 million.
- 3Establishes an advisory board, a supervisory board, and an independent managing entity selected through competition.
- 4Aims to counter adversarial foreign investment and signal technology priorities to private investors.
- 5Authorizes $975.5 million for fiscal year 2025 plus administrative and conditional funding.
Impact Areas
U.S. technology startupsbiotechnology firmsventure capital investorsDepartment of the Treasurydefense and commerce agenciesnational security community
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026